Key details
Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Enrollment target
~76 participants
Primary completion
January 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated February 2025